Synthesis and suggestion of a new nanometric gold(III) melatonin drug complex: an interesting model for testicular protection

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocytes1. J. Am. Chem. Soc. 80(10), 2587–2587 (1958).
  CASGoogle Scholar
• 2 Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia 49(8), 654–664 (1993).
  Medline CASGoogle Scholar
• 3 Tosini G, Baba K, Hwang CK, Iuvone PM. Melatonin: an underappreciated player in retinal physiology and pathophysiology. Exp. Eye Res. 103, 82–89 (2012).
  Medline CASGoogle Scholar
• 4 Tamarkin L, Baird CJ, Almeida O. Melatonin: a coordinating signal for mammalian reproduction? Science 227(4688), 714–720 (1985).
  Medline CASGoogle Scholar
• 5 Badness TJ, Powers JB, Hastings MH, Bittman EL, Goldman BD. The timed infusion paradigm for melatonin delivery: what has it taught us about the melatonin signal, its reception, and the photoperiodic control of seasonal responses? J. Pineal Res. 15(4), 161–190 (1993).
  MedlineGoogle Scholar
• 6 Lincoln G. Photoperiodism: melatonin as a seasonal time-cue: a commercial story. Nature 302(5911), 755 (1983).
  Medline CASGoogle Scholar
• 7 Arendt J. The Pineal Gland And Pineal Tumours. Endotext, MA, USA (2011).
  Google Scholar
• 8 Waldhauser F, Saletu B, Trinchard-Lugan I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology 100(2), 222–226 (1990).
  Medline CASGoogle Scholar
• 9 Holmes S, Sugden D. Effects of melatonin on sleep and neurochemistry in the rat. Br. J. Pharmacol. 76(1), 95–101 (1982).
  Medline CASGoogle Scholar
• 10 Maestroni GJ, Conti A, Pierpaoli W. Role of the pineal gland in immunity: circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J. Neuroimmunol. 13(1), 19–30 (1986).
  Medline CASGoogle Scholar
• 11 Cassone VM. Melatonin and suprachiasmatic nucleus function. In: Suprachiasmatic Nucleus: The Mind's Clock. Klein DC, Moore RY, Reppert SM (Eds). Oxford University Press, Oxford, UK, 309–323 (1991).
  Google Scholar
• 12 Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12(2), 151–180 (1991).
  Medline CASGoogle Scholar
• 13 Kilic ÜK. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol. J. Pharmacol. 56, 159–170 (2004).
  MedlineGoogle Scholar
• 14 Loots DT, Wiid IJ, Page BJ, Mienie LJ, Helden PD. Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model. J. Pineal Res. 38(2), 100–106 (2005).
  Medline CASGoogle Scholar
• 15 Omurtag GZ, Tozan A, Şehirli AÖ, Şener G. Melatonin protects against endosulfan-induced oxidative tissue damage in rats. J. Pineal Res. 44(4), 432–438 (2008).
  Medline CASGoogle Scholar
• 16 Manda K, Ueno M, Anzai K. Melatonin mitigates oxidative damage and apoptosis in mouse cerebellum induced by high-LET 56Fe particle irradiation. J. Pineal Res. 44(2), 189–196 (2008).
  Medline CASGoogle Scholar
• 17 Reiter RJ. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front. Neuroendocrinol. 16(4), 383–415 (1995).
  Medline CASGoogle Scholar
• 18 Halliwell B. Antioxidants in disease mechanisms and therapy. Adv. Pharmacol. 38, 3–17 (1997).
  Medline CASGoogle Scholar
• 19 Subala SP, Zubero EE, Alatorre-Jimenez MA, Shivakumar MS. Pre-treatment with melatonin decreases abamectin induced toxicity in a nocturnal insect Spodoptera litura (Lepidoptera: Noctuidae). Environ. Toxicol. Pharmacol. 56, 76–85 (2017).
  Medline CASGoogle Scholar
• 20 Flo A, Cambras T, Díez-Noguera A, Calpena A. Melatonin pharmacokinetics after transdermal administration changes according to the time of the day. Eur. J. Pharm. Sci. 96, 164–170 (2017).
  Medline CASGoogle Scholar
• 21 Kunak ZI, Macit E, Yaren H et al. Protective effects of melatonin and s-methylisothiourea on mechlorethamine induced nephrotoxicity. J. Surg. Res. 175(1), e17–e23 (2012).
  Medline CASGoogle Scholar
• 22 Roca J, Rodríguez MJ, Gil MA et al. Survival and in vitro fertility of boar spermatozoa frozen in the presence of superoxide dismutase and/or catalase. J. Androl. 26(1), 15–24 (2005).
  Medline CASGoogle Scholar
• 23 Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal. Biochem. 239(1), 70–76 (1996).
  Medline CASGoogle Scholar
• 24 Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal. Biochem. 16(2), 359–364 (1966).
  Medline CASGoogle Scholar
• 25 Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 196(2–3), 143–151 (1991).
  Medline CASGoogle Scholar
• 26 Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. FEBS J. 47(3), 469–474 (1974).
  CASGoogle Scholar
• 27 Corrin B. Carleton's histological technique. J. Clin. Pathol. 34(5), 572 (1981).
  Google Scholar
• 28 Westervelt R, Stouffer J, Hintz H, Schryver H. Estimating fatness in horses and ponies. J. Anim. Sci. 43(4), 781–785 (1976). •• Synthesis of new complexes.
  Google Scholar
• 29 Refat MS. Complexes of uranyl (II), vanadyl (II) and zirconyl (II) with orotic acid “vitamin B13”: synthesis, spectroscopic, thermal studies and antibacterial activity. J. Mol. Struct. 842(1–3), 24–37 (2007).
  CASGoogle Scholar
• 30 Nakamoto K, Nakamoto BK. Infrared Spectra of Inorganic and Coordination Compounds. John Wiley & Sons, Inc., Oxford, UK (1978).
  Google Scholar
• 31 Abdalrazaq EA, Buttrus NH, Al-Rahman A. Synthesis and characterization of gold (III) complexes with bis-(1, 4-Sodium thioglycolate) butane ligand. Asian J. Chem. 22(3), 2179 (2010).
  CASGoogle Scholar
• 32 Topal T, Ucar M, Gocgeldi E et al. Investigation of acute toxicity of a chemical warfare agent in kidneys. TAF Prev. Med. Bulletin 6(4), 227–232 (2007).
  Google Scholar
• 33 Kluth DC, Rees AJ. New approaches to modify glomerular inflammation. J. Nephrol. 12(2), 66–75 (1999).
  Medline CASGoogle Scholar
• 34 Korkmaz A, Yaren H, Topal T, Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch. Toxicol. 80(10), 662–670 (2006).
  Medline CASGoogle Scholar
• 35 Karbownik M, Reiter RJ. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc. Soc. Exp. Biol. Med. 225(1), 9–22 (2000).
  Medline CASGoogle Scholar
• 36 Reiter R. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9(7), 526–533 (1995).
  Medline CASGoogle Scholar
• 37 Yilmaz T, Celebi S, Kükner A. The protective effects of melatonin, vitamin E and octreotide on retinal edema during ischemia-reperfusion in the guinea pig retina. Eur. J. Ophthalmol. 12(6), 443–449 (2002).
  Medline CASGoogle Scholar
• 38 Irvine DS. Glutathione as a treatment for male infertility. Rev. Reprod. 1(1), 6–12 (1996).
  Medline CASGoogle Scholar
• 39 Jeulin C, Soufir J, Weber P, Laval-Martin D, Calvayrac R. Catalase activity in human spermatozoa and seminal plasma. Mol. Reprod. Dev. 24(2), 185–196 (1989).
  CASGoogle Scholar
• 40 Jang H, Kim Y, Kim B et al. Ameliorative effects of melatonin against hydrogen peroxide-induced oxidative stress on boar sperm characteristics and subsequent in vitro embryo development. Reprod. Domest. Anim. 45(6), 943–950 (2010).
  Medline CASGoogle Scholar
• 41 Du Plessis S, Hagenaar K, Lampiao F. The in vitro effects of melatonin on human sperm function and its scavenging activities on NO and ROS. Andrologia 42(2), 112–116 (2010).
  Medline CASGoogle Scholar
• 42 Succu S, Berlinguer F, Pasciu V, Satta V, Leoni GG, Naitana S. Melatonin protects ram spermatozoa from cryopreservation injuries in a dose-dependent manner. J. Pineal Res. 50(3), 310–318 (2011).
  Medline CASGoogle Scholar
• 43 López A, García JA, Escames G et al. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J. Pineal Res. 46(2), 188–198 (2009).
  Medline CASGoogle Scholar
• 44 Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res. 48(4), 297–310 (2010).
  Medline CASGoogle Scholar
• 45 Baumber J, Ball BA, Gravance CG, Medina V, Davies-Morel MC. The effect of reactive oxygen species on equine sperm motility, viability, acrosomal integrity, mitochondrial membrane potential, and membrane lipid peroxidation. J. Androl. 21(6), 895–902 (2000).
  Medline CASGoogle Scholar
• 46 Ashrafi I, Kohram H, Ardabili FF. Antioxidative effects of melatonin on kinetics, microscopic and oxidative parameters of cryopreserved bull spermatozoa. Anim. Reprod. Sci. 139(1–4), 25–30 (2013).
  Medline CASGoogle Scholar
• 47 Lector C. Oxidative stress and role of antioxidants in normal and abnormal sperm function. Front. Biosci. 1, e78–e86 (1996).
  MedlineGoogle Scholar
• 48 Gavella M, Lipovac V. Antioxidative effect of melatonin on human spermatozoa. Arch. Androl. 44(1), 23–27 (2000).
  Medline CASGoogle Scholar
• 49 Jou MJ, Peng TI, Yu PZ et al. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J. Pineal Res. 43(4), 389–403 (2007).
  Medline CASGoogle Scholar
• 50 Casao A, Mendoza N, Pérez-Pé R et al. Melatonin prevents capacitation and apoptotic-like changes of ram spermatozoa and increases fertility rate. J. Pineal Res. 48(1), 39–46 (2010).
  Medline CASGoogle Scholar
• 51 Succu S, Berlinguer F, Pasciu V, Satta V, Leoni GG, Naitana S. Melatonin protects ram spermatozoa from cryopreservation injuries in a dose-dependent manner. J. Pineal Res. 50(3), 310–318 (2011).
  Medline CASGoogle Scholar
• 52 Fujinoki M. Melatonin-enhanced hyperactivation of hamster sperm. Reproduction 136(5), 533–541 (2008). • Mechanism of antioxidant enzymes.
  Medline CASGoogle Scholar
• 53 El-Shenawy NS, Hamza RZ, Khaled HE. Protective effect of α–lipoic acid against spleen toxicity of dimethylnitrosamine in male mice: antioxidant and ultrastructure approaches. Biomed. Pharmacother. 96, 459–465 (2017). •• Capacities of synthesized complexes due to complexity between metal ions and some active compounds and drugs.
  Medline CASGoogle Scholar
• 54 El-Megharbel SM, Hamza RZ, Refat MS. Preparation, spectroscopic, thermal, antihepatotoxicity, hematological parameters and liver antioxidant capacity characterizations of Cd (II), Hg (II), and Pb (II) mononuclear complexes of paracetamol anti-inflammatory drug. Spectrochim. Acta A Mol. Biomol. Spectrosc. 131, 534–544 (2014).
  Medline CASGoogle Scholar
• 55 El-Megharbel SM, Hamza RZ, Refat MS. Synthesis, chemical identification, antioxidant capacities and immunological evaluation studies of a novel silver (I) carbocysteine complex. Chem. Biol. Interact. 220, 169–180 (2014).
  Medline CASGoogle Scholar
• 56 El-Megharbel SM, Hamza RZ, Refat MS. Synthesis, spectroscopic and thermal studies of Mg (II), Ca (II), Sr (II) and Ba (II) diclofenac sodium complexes as anti-inflammatory drug and their protective effects on renal functions impairment and oxidative stress. Spectrochim. Acta A Mol. Biomol. Spectrosc. 135, 915–928 (2015).
  Medline CASGoogle Scholar
• 57 El-Megharbel SM, Hamza RZ, Refat MS. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl (IV) adenine complex prospective as antidiabetic drug agent. Spectrochim. Acta A Mol. Biomol. Spectrosc. 135, 850–864 (2015).
  Medline CASGoogle Scholar
• 58 El-Megharbel S, Hamza R, Refat M, Al-Omar M, Naglah A. Effect of indomethacin and its complexes on reproductive performance and oxidative stress in testis and stomach of male albino rats with reference to their chemical characterizations. J. Biol. Regul. Homeost. Agents 29(3), 619–636 (2015).
  Medline CASGoogle Scholar
• 59 Refat MS, El-Megharbel SM, Hussien M et al. Spectroscopic, structural characterizations and antioxidant capacity of the chromium (III) niacinamide compound as a diabetes mellitus drug model. Spectrochim. Acta A Mol. Biomol. Spectrosc. 173, 122–131 (2017).
  Medline CASGoogle Scholar